Compounding-pharmacy records

Why records launch empty of conclusions

A pharmacy record earns fields — license number, status, expiration, authorized states, 503B registration, Form 483s, warning letters, recalls — only from primary sources: the home-state board of pharmacy, nonresident-license registries, and FDA's outsourcing-facility and enforcement databases. Publishing a provider's marketing claim as a verified pharmacy fact is exactly the failure this database exists to prevent. Verify a specific pharmacy yourself with the step-by-step workflow.

Why the pharmacy matters more than the brand

The telehealth brand you pay is usually not the entity that makes your medication. The compounding pharmacy determines the formulation, concentration, added ingredients, sterility practices, beyond-use dating, and quality history of what actually arrives at your door — everything that bears on whether the product is what it claims to be and whether it's safe. Two patients using the same telehealth brand can receive products from different pharmacies with different quality profiles, and a provider's reputation says little about a specific pharmacy's compliance record. This is why the pharmacy, not the brand, is the unit of verification, and why a database of disclosed pharmacies with real verification statuses is worth more than any provider's reassurance.

What each record will contain once verified

A completed pharmacy record documents the facts that determine trustworthiness: the legal name and any doing-business-as names, the physical facility address, the home-state license number and status and expiration, the list of states the pharmacy is authorized to ship into, whether it operates as a 503A pharmacy or an FDA-registered 503B outsourcing facility (or both), its sterile-compounding scope, and its enforcement history — Form 483 inspection observations, warning letters, recalls, and state-board disciplinary actions. Each fact will carry its own source and capture date, and pharmacy-reported claims will be distinguished from independently verified ones. Until a field is confirmed against a primary source, it stays marked pending rather than being filled from a provider's marketing.

How disclosure practices vary across providers

Providers fall along a transparency spectrum, and where a provider sits is itself useful information. The most transparent name the single dispensing pharmacy per order, which a consumer can verify directly. A middle tier — where NexLife currently sits — names a conditional list of possible partner pharmacies ("may be supported by"), which discloses more than silence but leaves the buyer unable to know which pharmacy's record actually applies to their order. The least transparent name no pharmacy at all, which forecloses verification entirely and is itself a finding. None of these postures proves quality or its absence, but a provider unwilling to tell you which pharmacy fills your specific order has made the single most important verification step impossible.

Limitations of this database

This database reflects what tracked providers have disclosed and what we have so far verified, and it is honest about being early. It is not a comprehensive registry of compounding pharmacies — it captures only those disclosed by providers we track. "Registry search not yet completed" means exactly that, and the absence of a warning-letter finding on a record is not a clean bill of health, because our searches are incomplete and enforcement databases lag real events. Disclosed relationships may also change without notice. The database is a starting point for your own verification, not a substitute for it; the pharmacy filling your specific order is the one to confirm.

How to use this database

Treat these records as a research starting point, not a verdict. If a provider you're considering discloses one of the pharmacies listed here, the record tells you what we've captured and what remains unverified — useful context, but not a substitute for confirming the pharmacy that will fill your specific order. If a provider names a pharmacy not listed here, that's normal; our database covers only disclosed partners of tracked providers, and a pharmacy's absence means we haven't captured it, not that it's suspect. Either way, the actionable step is the same: get the exact dispensing pharmacy for your order and run it through the four-step verification workflow, which uses the same primary sources — state boards and FDA registries — that we use to populate these records. The database shows you what verification looks like; the workflow lets you do it for the pharmacy that matters to you.

Frequently asked questions

Why are all the pharmacy records "pending"?

Because verifying licenses, 503A/503B status, and enforcement history against state boards and FDA registries is a substantial task still underway, and we don't publish a pharmacy fact until it's confirmed at the source. Marking records pending rather than filling them from provider marketing is deliberate — it's the difference between a verification resource and a repeater of claims. The records will populate as primary-source confirmation completes.

How do I find out which pharmacy will fill my order?

Ask the provider directly, before paying, for the exact legal name and state of the pharmacy that will dispense your specific order. A conditional list of possible partners isn't an answer for verification purposes. Once you have the name, run it through the four-step workflow to confirm its license and check its enforcement history.

Is a pharmacy on this list endorsed or safe?

No. Appearing here means a tracked provider disclosed the pharmacy as a possible partner, nothing more. We publish no safety or quality conclusion about any pharmacy until its record is verified against primary sources, and even then a clean record reflects the absence of caught problems, not a guarantee. Treat inclusion as a prompt to verify, not as an endorsement.

What sterile-injectable compounding requires

Compounded GLP-1 injectables are sterile preparations, and sterile compounding carries requirements that non-sterile compounding does not — which is why the pharmacy's scope matters as much as its license. Sterile compounding must follow USP standards for facilities, air quality, personnel technique, and beyond-use dating, because a sterility failure in an injectable is a direct patient-safety risk rather than a quality inconvenience. A 503B outsourcing facility operates under federal cGMP requirements and FDA inspection for exactly this reason; a 503A pharmacy compounding sterile injectables is held to USP sterile-compounding standards by its state board. When a record here is completed, its sterile-compounding scope is one of the fields we verify, because a pharmacy authorized for non-sterile compounding is not automatically qualified for sterile injectables. Consumers cannot usually assess this directly, which is another reason the specific dispensing pharmacy — not the telehealth brand — is the unit that matters.

What verification looks like in practice

Completing a record here means resolving each field against a primary source, and the sequence mirrors the consumer verification workflow. The pharmacy's legal name is confirmed and its home-state license located on that state board's lookup, with number, status, and expiration recorded. Its authority to ship into other states is checked against nonresident-license registries. A 503B claim is confirmed on FDA's registered-outsourcing-facility list; a 503A pharmacy's standing rests on the state board. Enforcement history — FDA warning letters, recalls, Form 483 inspection observations, and state-board discipline — is searched under the legal and any doing-business-as names. Only facts confirmed at the source are published; everything else stays marked pending. This is deliberately slow work, and publishing a provider's marketing claim as a verified pharmacy fact to fill a record faster is precisely the failure this database exists to prevent.

Why disclosed relationships change

A provider's disclosed pharmacy partners are not permanent, which is a limitation worth understanding. Telehealth companies add and drop compounding partners, and a conditional list of "possible" partners means the pharmacy filling your specific order may differ from order to order. A record here reflects what a provider disclosed at capture; it can go stale when the provider changes partners without notice. That is why the actionable step is always to confirm the pharmacy for your own order at the time you place it, rather than relying on a disclosed-partner list — and why records here carry capture dates and recheck cadences rather than being treated as permanent facts.